Revvity, Inc. is a diversified company operating in the diagnostics and life sciences sectors. Their broad range of products and services supports various industries from healthcare to agriculture. The company's strategic operations focus on revolutionizing scientific breakthroughs worldwide.
Revvity, Inc. shows a moderate fundamental standing with balanced scores across financial categories.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 3 | |
Return on Equity | 3 | |
Return on Assets | 4 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 3 |
The historical data reflects Revvity's consistent performance in its key financial metrics.
Date | Overall Score | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
---|---|---|---|---|---|---|---|
2025-04-15 | 3 | 3 | 3 | 4 | 1 | 1 | 3 |
Previous | 0 | 3 | 3 | 4 | 1 | 1 | 3 |
Analysts predict a stable price outlook with close clustering in their projections.
High | Low | Median | Consensus |
---|---|---|---|
140 | 130 | 132 | 134 |
The sentiment among analysts shows a general consensus of optimism with no bearish outlooks.
Recommendation | Number | Distribution |
---|---|---|
Strong Buy | 0 | |
Buy | 17 | |
Hold | 12 | |
Sell | 0 | |
Strong Sell | 0 |
Revvity, Inc. showcases a solid footprint in the healthcare industry with diversified business segments. While its financial ratios suggest an average performance, the company has strong prospects with positive analyst sentiment. However, careful monitoring of the debt-to-equity dynamics is advisable. Overall, Revvity represents a balanced investment opportunity for cautious investors seeking medium-term growth.